Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1987 3
1988 1
1989 2
1990 1
1992 1
1994 4
1995 3
1996 1
1997 2
1998 3
1999 2
2000 1
2002 1
2003 2
2004 1
2005 3
2006 5
2007 1
2008 2
2010 4
2011 15
2012 17
2013 2
2015 4
2016 3
2017 1
2020 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
Novel poly(ADP-ribose) polymerase-1 inhibitors.
Dunn D, Husten J, Ator MA, Chatterjee S. Dunn D, et al. Among authors: ator ma. Bioorg Med Chem Lett. 2012 Jan 1;22(1):222-4. doi: 10.1016/j.bmcl.2011.11.032. Epub 2011 Nov 17. Bioorg Med Chem Lett. 2012. PMID: 22153339
Novel Macrocyclic Antagonists of the Calcitonin Gene-Related Peptide Receptor: Design, Realization, and Structural Characterization of Protein-Ligand Complexes.
Cansfield AD, Ator MA, Banerjee J, Bestwick M, Bortolato A, Brown GA, Brown J, Butkovic K, Cansfield JE, Christopher JA, Congreve M, Cseke G, Deflorian F, Dugan B, Hunjadi MP, Hutinec A, Inturi TK, Landek G, Mason J, O'Brien A, Ott GR, Rupcic R, Saxty G, Southall SM, Zadravec R, Watson SP. Cansfield AD, et al. Among authors: ator ma. ACS Chem Neurosci. 2022 Mar 16;13(6):751-765. doi: 10.1021/acschemneuro.1c00696. Epub 2022 Mar 4. ACS Chem Neurosci. 2022. PMID: 35245037
Overview of drug discovery and development.
Ator MA, Mallamo JP, Williams M. Ator MA, et al. Curr Protoc Pharmacol. 2006 Dec;Chapter 9:Unit9.9. doi: 10.1002/0471141755.ph0909s35. Curr Protoc Pharmacol. 2006. PMID: 22294181
3-(1'-Cyclobutylspiro[4H-1,3-benzodioxine-2,4'-piperidine]-6-yl)-5,5-dimethyl-1,4-dihydropyridazin-6-one (CEP-32215), a new wake-promoting histamine H3 antagonist/inverse agonist.
Hudkins RL, Gruner JA, Raddatz R, Mathiasen JR, Aimone LD, Marino MJ, Bacon ER, Williams M, Ator MA. Hudkins RL, et al. Among authors: ator ma. Neuropharmacology. 2016 Jul;106:37-45. doi: 10.1016/j.neuropharm.2015.09.025. Epub 2015 Sep 21. Neuropharmacology. 2016. PMID: 26400408
Proteasome inhibitors for cancer therapy.
Iqbal M, Messina McLaughlin PA, Dunn D, Mallya S, Husten J, Ator MA, Chatterjee S. Iqbal M, et al. Among authors: ator ma. Bioorg Med Chem. 2012 Apr 1;20(7):2362-8. doi: 10.1016/j.bmc.2012.02.007. Epub 2012 Feb 11. Bioorg Med Chem. 2012. PMID: 22377673
Novel poly(ADP-ribose) polymerase-1 inhibitors.
Dunn D, Husten J, Ator MA, Chatterjee S. Dunn D, et al. Among authors: ator ma. Bioorg Med Chem Lett. 2007 Jan 15;17(2):542-5. doi: 10.1016/j.bmcl.2006.10.010. Epub 2006 Oct 10. Bioorg Med Chem Lett. 2007. PMID: 17074482
4-Quinazolinyloxy-diaryl ureas as novel BRAFV600E inhibitors.
Holladay MW, Campbell BT, Rowbottom MW, Chao Q, Sprankle KG, Lai AG, Abraham S, Setti E, Faraoni R, Tran L, Armstrong RC, Gunawardane RN, Gardner MF, Cramer MD, Gitnick D, Ator MA, Dorsey BD, Ruggeri BR, Williams M, Bhagwat SS, James J. Holladay MW, et al. Among authors: ator ma. Bioorg Med Chem Lett. 2011 Sep 15;21(18):5342-6. doi: 10.1016/j.bmcl.2011.07.019. Epub 2011 Jul 14. Bioorg Med Chem Lett. 2011. PMID: 21807507
P2-proline-derived inhibitors of calpain I.
Tripathy R, Gu ZQ, Dunn D, Senadhi SE, Ator MA, Chatterjee S. Tripathy R, et al. Among authors: ator ma. Bioorg Med Chem Lett. 1998 Oct 6;8(19):2647-52. doi: 10.1016/s0960-894x(98)00470-3. Bioorg Med Chem Lett. 1998. PMID: 9873596
Wake-promoting agents: search for next generation modafinil: part I.
Dunn D, Hostetler G, Iqbal M, Messina-McLaughlin P, Reiboldt A, Lin YG, Gruner J, Bacon ER, Ator MA, Chatterjee S. Dunn D, et al. Among authors: ator ma. Bioorg Med Chem Lett. 2012 Mar 15;22(6):2312-4. doi: 10.1016/j.bmcl.2011.12.099. Epub 2011 Dec 29. Bioorg Med Chem Lett. 2012. PMID: 22264475
Combined inhibition of atypical PKC and histone deacetylase 1 is cooperative in basal cell carcinoma treatment.
Mirza AN, Fry MA, Urman NM, Atwood SX, Roffey J, Ott GR, Chen B, Lee A, Brown AS, Aasi SZ, Hollmig T, Ator MA, Dorsey BD, Ruggeri BR, Zificsak CA, Sirota M, Tang JY, Butte A, Epstein E, Sarin KY, Oro AE. Mirza AN, et al. Among authors: ator ma. JCI Insight. 2017 Nov 2;2(21):e97071. doi: 10.1172/jci.insight.97071. JCI Insight. 2017. PMID: 29093271 Free PMC article.
76 results